Amarin (AMRN), FDA Enter REDUCE-IT SPA; Second Efficacy Analysis Added
Amarin Corporation plc (NASDAQ: AMRN) announced that the U.S. Food and Drug Administration (FDA) agreed to an amendment of the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)